64
Participants
Start Date
October 31, 2011
Primary Completion Date
October 13, 2014
Study Completion Date
November 27, 2017
Ixazomib
Ixazomib capsules
Lenalidomide
Lenalidomide capsules
Dexamethasone
Dexamethasone Tablets
Memorial Sloan Kettering Cancer Center, New York
Associates of Oncology/Hematology PC, Rockville
Virginia Cancer Care Specialist, Fairfax
Virginia Cancer Specialists PC, Fairfax
Duke University Medical Center, Durham
Mount Sinai Hospital, New York
H Lee Moffitt Cancer Center and Research Institute, Tampa
SCRI Tennessee Oncology Nashville, Nashville
Ohio State University, Columbus
Mercy St Anne Hospital, Toledo
University of Michigan, Ann Arbor
Michigan State University, Lansing
University of Chicago Medical Center, Chicago
Baylor Sammons Cancer Center, Dallas
City of Hope National Medical Center, Duarte
Stanford University, Stanford
UCSF Medical Center, Berkeley
Oregon Health and Science University, Portland
Dana Farber Cancer Institute, Boston
Hackensack University Medical Center, Hackensack
Lead Sponsor
Millennium Pharmaceuticals, Inc.
INDUSTRY